Dose-Escalation Study Evaluating the Safety and Pharmacokinetics of Artesunate in Patients With Hepatocellular Carcinoma

NCT02304289 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
2
Enrollment
OTHER
Sponsor class

Stopped slow recruitment of patients

Conditions

Interventions

Sponsor

University Hospital, Ghent

Collaborators